» Articles » PMID: 30233553

APOBEC3B Activity Is Prevalent in Urothelial Carcinoma Cells and Only Slightly Affected by LINE-1 Expression

Overview
Journal Front Microbiol
Specialty Microbiology
Date 2018 Sep 21
PMID 30233553
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The most common mutational signature in urothelial carcinoma (UC), the most common type of urinary bladder cancer is assumed to be caused by the misdirected activity of APOBEC3 (A3) cytidine deaminases, especially A3A or A3B, which are known to normally restrict the propagation of exogenous viruses and endogenous retroelements such as LINE-1 (L1). The involvement of A3 proteins in urothelial carcinogenesis is unexpected because, to date, UC is thought to be caused by chemical carcinogens rather than viral activity. Therefore, we explored the relationship between A3 expression and L1 activity, which is generally upregulated in UC. We found that UC cell lines highly express A3B and in some cases A3G, but not A3A, and exhibit corresponding cytidine deamination activity . While we observed evidence suggesting that L1 expression has a weak positive effect on A3B and A3G expression and A3B promoter activity, neither efficient siRNA-mediated knockdown nor overexpression of functional L1 elements affected catalytic activity of A3 proteins consistently. However, L1 knockdown diminished proliferation of a UC cell line exhibiting robust endogenous L1 expression, but had little impact on a cell line with low L1 expression levels. Our results indicate that UC cells express A3B at levels exceeding A3A levels by far, making A3B the prime candidate for causing genomic mutations. Our data provide evidence that L1 activation constitutes only a minor and negligible factor involved in induction or upregulation of endogenous A3 expression in UC.

Citing Articles

New insights into ATR inhibition in muscle invasive bladder cancer: The role of apolipoprotein B mRNA editing catalytic subunit 3B.

Kim H, Cho U, Hong S, Park H, Kim I, An H Oncol Res. 2024; 32(6):1021-1030.

PMID: 38827321 PMC: 11136685. DOI: 10.32604/or.2024.048919.


Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.

Lokeshwar S, Lopez M, Sarcan S, Aguilar K, Morera D, Shaheen D Cancers (Basel). 2022; 14(11).

PMID: 35681556 PMC: 9179261. DOI: 10.3390/cancers14112578.


Proteomic and transcriptomic profiles of human urothelial cancer cells with histone deacetylase 5 overexpression.

Vasudevan A, Hoffmann M, Poschmann G, Petzsch P, Wiek C, Stuhler K Sci Data. 2022; 9(1):240.

PMID: 35624179 PMC: 9142574. DOI: 10.1038/s41597-022-01319-0.


Foamy Viruses, Bet, and APOBEC3 Restriction.

Vasudevan A, Becker D, Luedde T, Gohlke H, Munk C Viruses. 2021; 13(3).

PMID: 33803830 PMC: 8003144. DOI: 10.3390/v13030504.


Many Different LINE-1 Retroelements Are Activated in Bladder Cancer.

Whongsiri P, Goering W, Lautwein T, Hader C, Niegisch G, Kohrer K Int J Mol Sci. 2020; 21(24).

PMID: 33322422 PMC: 7763009. DOI: 10.3390/ijms21249433.


References
1.
Tolstov Y, Hadaschik B, Pahernik S, Hohenfellner M, Duensing S . Human papillomaviruses in urological malignancies: a critical assessment. Urol Oncol. 2013; 32(1):46.e19-27. DOI: 10.1016/j.urolonc.2013.06.012. View

2.
Thielen B, McNevin J, McElrath M, Vander Stoep Hunt B, Klein K, Lingappa J . Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms. J Biol Chem. 2010; 285(36):27753-66. PMC: 2934643. DOI: 10.1074/jbc.M110.102822. View

3.
Skowronski J, Fanning T, Singer M . Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol. 1988; 8(4):1385-97. PMC: 363295. DOI: 10.1128/mcb.8.4.1385-1397.1988. View

4.
Takeuchi H, Tanaka M, Tanaka A, Tsunemi A, Yamamoto H . Predominance of M2-polarized macrophages in bladder cancer affects angiogenesis, tumor grade and invasiveness. Oncol Lett. 2016; 11(5):3403-3408. PMC: 4841030. DOI: 10.3892/ol.2016.4392. View

5.
Harris R, Dudley J . APOBECs and virus restriction. Virology. 2015; 479-480:131-45. PMC: 4424171. DOI: 10.1016/j.virol.2015.03.012. View